Voyager Therapeutics Inc (VYGR) Stock Price, Quote, News & History

VYGRNASDAQ
$3.37
0.041.20%
At close: Jun 8, 5:00 PM EST
$3.37
N/A
After Hours: 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-127.99M
Investing Cash Flow (TTM)
92.35M
Financing Cash Flow (TTM)
4.07M
Free Cash Flow (TTM)
-129.94M
Capital Expenditure (TTM)
-1.95M
Net Change in Cash (TTM)
-31.58M

Analyst Trends and Forecast

1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$121.78M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
5.37
PB Ratio (TTM)
1.16
Earnings Yield % (TTM)
-59.64%
Earnings Yield % (FWD)
-48.49%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.87

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$43.31M
Debt to Equity
0.20
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.40
Close
$3.37
Volume / Avg.
448.91K / 680.57K
Day Range
$3.28 - $3.58
52 Wk Range
2.83 - 5.55
Market Cap
$203.62M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
6.75%
Days to Cover
6.42

About

Sector
Health Care
Industry
Biotechnology
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Voyager Therapeutics (VYGR) stock?

A

You can purchase shares of Voyager Therapeutics (NASDAQ:VYGR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Voyager Therapeutics (VYGR) competitors?

A

There are no as such competitors for Voyager Therapeutics.

Q

What is the forecast, or price target, for Voyager Therapeutics (VYGR) stock?

A

Voyager Therapeutics has a consensus price target of $15.91.

Q

What is the current price for Voyager Therapeutics (VYGR)?

A

The stock price for Voyager Therapeutics (NASDAQ: VYGR) is $3.37 last updated June 8, 2026 at 4:00 PM EDT.

Q

Does Voyager Therapeutics (VYGR) pay a dividend?

A

There are no upcoming dividends for Voyager Therapeutics.

Q

When is Voyager Therapeutics (NASDAQ:VYGR) reporting earnings?

A

Voyager Therapeutics does not have any upcoming earnings scheduled.

Q

Is Voyager Therapeutics (VYGR) going to split?

A

There is no upcoming split for Voyager Therapeutics.

Q

What sector and industry does Voyager Therapeutics (VYGR) operate in?

A

Voyager Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.